Novo Integrated jumps on getting patent for tech to make oral pouches
** Novo Integrated Sciences' shares NVOS.O up 8.6% at
$3.27 premarket after subsidiary PRO-DIP, LLC gets patent in the
U.S. for technology to manufacture its oral supplement pouches
urn:newsml:reuters.com:*:nBw4nG9dka
** Peter St. Lawrence, president of PRO-DIP, says patent
ensures commercial protection as it develops and distributes new
category of products for hydration, immunity and sleep, among
others
** Up to Wednesday's close, stock had risen 115% YTD
(Reporting by Leroy Leo in Bengaluru)
((Leroy.Dsouza@thomsonreuters.com ; Twitter: https://twitter.com/LeroyLeo7;))
Recent news on Novo Integrated Sciences
See all newsBrief: Novo Integrated Sciences Says On Nov 4, Got Letter From Nasdaq Indicating Co's Common Stock Will Be Delisted From Nasdaq
Brief: Novo Integrated Sciences Gets Commencement Of Disbursement Notice For SBLC Leasing And Monetizing Program
Brief: Novo Integrated Sciences Inc Files For Offering Of 3.5 Million Shares Of Common Stock By Selling Securityholder - SEC Filing
Brief: Novo Integrated Sciences Receives Confirmation Of Issuance Of SBLC By HSBC
U.S. STOCKS ON THE MOVE-Nordstrom, Foot Locker, VF Corp